✦ LIBER ✦

The BCL2 code to dopaminergic development and Parkinson's disease

✍ Scribed by van der Heide, Lars P.; Smidt, Marten P.

Book ID: 120215098
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 548 KB
Volume: 19
Category: Article
ISSN: 1471-4914
DOI: 10.1016/j.molmed.2013.02.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Parkinson's Disease (Non-Motor and Non-D

Parkinson's Disease (Non-Motor and Non-Dopaminergic Features) || Non-Dopaminergic Approaches to the Treatment of Parkinson's Disease

✍ Olanow, C. Warren; Stocchi, Fabrizio; Lang, Anthony E. 📂 Article 📅 2011 🏛 Blackwell Publishing Ltd. ⚖ 700 KB

2.IS.2.3 Depression and Parkinson's dise

2.IS.2.3 Depression and Parkinson's disease – The dopaminergic link

✍ A.F.G. Leentjens 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Parkinson's disease and RLS: the dopamin

Parkinson's disease and RLS: the dopaminergic bridge

✍ David B Rye 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Non-dopaminergic treatments in developme

Non-dopaminergic treatments in development for Parkinson's disease

✍ Susan H Fox; Jonathan M Brotchie; Anthony E Lang 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 368 KB

Central dopaminergic receptor supersensi

Central dopaminergic receptor supersensitivity and its relevance to Parkinson's disease

✍ C.J. Pycock; C.D. Marsden 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 556 KB

Predictors of time to requiring dopamine

Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts

✍ Connie Marras; Michael P. McDermott; Ken Marek; Paula Rochon; Gary Naglie; Carol 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

## Abstract The rate of progression of Parkinson's disease (PD) is highly variable. Knowledge of factors associated with disease milestones and commonly used research outcome measures helps with patient counseling and guides the design and interpretation of clinical studies. The objective of the st